Formic Acid

Formic Acid

SCHEMBL30219804

NNC(=O)Cc1ccc[n+](Cc2ccccc2)c1.O=CO.O=C[O-]

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP2D6 P10635 1/20 0.42
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALDH1A1 P00352 1/20 0.38
ACHE P22303 3/20 0.38
HSP90AA1 P07900 3/20 0.36
AOC2 O75106 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26087979 0.91 NPSR1 (0.56) NPSR1L3MBTL1CYP2D6LMNACYP1A2
Formic Acid SCHEMBL30801354 0.82 NOTUM (0.38) L3MBTL1AOC2CA12CA1CA2
Formic Acid SCHEMBL30801353 0.82 NOTUM (0.38) L3MBTL1AOC2CA12CA1CA2
Formic Acid SCHEMBL26087463 0.80 NPSR1 (0.47) NPSR1L3MBTL1LMNAALDH1A1ACHE
SCHEMBL26149648 0.78 L3MBTL1 (0.42) NPSR1L3MBTL1CYP2D6LMNACYP1A2
SCHEMBL11509120 0.76 L3MBTL1 (0.58) NPSR1L3MBTL1CYP2D6LMNACYP1A2
SCHEMBL26497772 0.75 AOC2 (0.51) NPSR1L3MBTL1CYP2D6CYP1A2CYP3A4
SCHEMBL26414135 0.74 L3MBTL1 (0.46) NPSR1L3MBTL1CYP1A2CYP3A4CYP2C9
Trifluoroacetic Acid SCHEMBL30320103 0.74 L3MBTL1 (0.37) NPSR1L3MBTL1CYP2D6LMNACYP1A2
Hydrochloric Acid SCHEMBL11510418 0.73 NPSR1 (0.58) NPSR1L3MBTL1CYP2D6LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4153565-B1 BENZYLPYRIDINIUM REAGENT FOR MASS SPECTROMETRY HOFFMANN LA ROCHE (CH) 2026-02-18 EP disclosed
US-12424426-B2 Benzylpyridinium reagent for mass spectrometry ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2025-09-23 US disclosed
US-20230127289-A1 BENZYLPYRIDINIUM REAGENT FOR MASS SPECTROMETRY ROCHE DIAGNOSTICS GMBH (DE) 2023-04-27 US disclosed
EP-4153565-A1 BENZYLPYRIDINIUM REAGENT FOR MASS SPECTROMETRY F. Hoffmann-La Roche AG (CH) 2023-03-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127289-A1 BENZYLPYRIDINIUM REAGENT FOR MASS SPECTROMETRY SRMS, PTMS, BRD4 NPSR1 2660/4885L3MBTL1 1054/4885CYP2D6 163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.